Julian Baker, cofounder of Baker Bros. Advisors, is one of the most successful investors in the biotechnology industry, building a multibillion-dollar hedge fund focused on high-conviction positions in drug development and life sciences. Together with his brother Felix, he has backed breakthrough therapeutics and major biotech companies including Seagen, Incyte, and Alexion, often taking large, long-term positions and working closely with management teams. Known for rigorous scientific analysis, patience, and a deep understanding of clinical risk, Baker has become a central figure in biotech capital markets, influencing the trajectory of drug innovation while maintaining one of the top track records in the sector.

Joseph Edelman, founder and CEO of Perceptive Advisors, is one of the most successful and influential biotech hedge fund managers of the modern era. Since launching the firm in 1999, he has built Perceptive into a multibillion-dollar powerhouse specializing in life sciences, backing breakthrough companies across biotechnology, medical devices, and healthcare innovation. Known for his deep scientific understanding, high-conviction portfolio strategy, and early identification of transformative therapies, Edelman has consistently ranked among the top performers in healthcare investing. His disciplined, research-driven approach has made Perceptive a critical source of capital for emerging biotech and a defining force in the global life sciences ecosystem.